SCHEMBL4497287

SCHEMBL4497287

CN(C)CCCOc1cc(F)c(-c2c(Cl)nc(-n3cccn3)c(=O)n2-c2cccc(F)c2)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
ESR1 P03372 2/20 0.36
KDM4E B2RXH2 2/20 0.34
MET P08581 1/20 0.34
FGFR1 P11362 2/20 0.33
SRC P12931 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TGFBR1 P36897 1/20 0.32
MAT2A P31153 1/20 0.32
CACNA2D1 P54289 1/20 0.32
KDR P35968 1/20 0.31
ALDH1A2 O94788 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ALDH1A3 P47895 1/20 0.31
MAOB P27338 1/20 0.31
CDK2 P24941 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4261005 0.89 HRH3 (0.35) KDM4ETGFBR1MAT2ACACNA2D1ALDH1A2
SCHEMBL4877684 0.84 MAT2A (0.39) KDM4ESMN1; SMN2TGFBR1MAT2AMEN1
SCHEMBL4745295 0.81 KDM4E (0.32) KDM4EFGFR1
SCHEMBL4489416 0.81 KDM4E (0.32) KDM4EFGFR1
SCHEMBL4490928 0.80 KDM4E (0.32) KDM4EFGFR1
SCHEMBL4490917 0.79 BPTF (0.31) KDM4EFGFR1
SCHEMBL13788904 0.76 MAT2A (0.42) KDM4ESMN1; SMN2MAT2AALDH1A2ALDH1A1
SCHEMBL4482238 0.75 LYN (0.32) SRCCDK2
SCHEMBL4882519 0.75 MAT2A (0.45) KDM4EMAT2AALDH1A1
SCHEMBL4882430 0.71 MAT2A (0.46) KDM4ESMN1; SMN2MAT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors E.I. DUPONT DE NEMOURS AND COMPANY (US) 2009-07-23 US claimed
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors E.I. DUPONT DE NEMOURS AND COMPANY (US) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors MKI67, NR0B1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 HTR2A 3314/4885HTR2C 2033/4885HTR2B 2256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.